FDA says decision to put silicon breast implants back on market was the right one

The FDA was criticized in 2006 for approving the controversial implants after they'd been off the market for 14 years. But the organization says research in the last five years has shown the implants have 'reasonable assurance of safety and effectiveness.'The FDA was criticized in 2006 for approving the controversial implants after they'd been off the market for 14 years. But the organization says research in the last five years has shown the implants have 'reasonable assurance of safety and effectiveness.'

Read the whole article on LA Times - Health

More from LA Times - Health